The platform · how VitaCrypt works

Four pillars. One unified profile.

Most health tools do one of these. VitaCrypt does all four, and the value is in how they compound.

A unified data fabric built to ingest any health signal; every recommendation cited to live science; personalization down to your genotype and local environment; and privacy built in by design, so centralizing this data never means exposing it. Here is how each one works.

Pillar 01 · Unified

Every health signal, fused into one profile.

VitaCrypt pulls each source and normalizes it into one schema, so scattered data becomes a single queryable profile, built to fold in any health signal and grow over time. The privacy pillar is built so that profile is encrypted under your key and the server works with one ciphertext, not a separate plaintext feed per source.

  1. 1
    Connect or upload

    Wearables connect via Apple Health export today, with direct device APIs on the build path; DNA, microbiome and lab files are uploaded; environment is pulled from your location.

  2. 2
    Normalize into one schema

    Different formats (VCF, FHIR, CSV, JSON) are mapped into one queryable health schema.

  3. 3
    Encrypt under your key

    In the target custody model, the unified profile is encrypted with a key held in your iOS Keychain / Android Keystore. The design goal: plaintext never leaves the device.

What's connected, and when

SourceWhat it addsAvailability
GeneticsVariants that reshape every other signal: folate cycle, lipids, caffeine, methylationAt MVP launch23andMe / Ancestry upload
WearablesHRV, sleep stages, recovery, resting heart, activity loadAt MVP launchApple Health export today; direct device APIs on the build path · Apple Watch, Oura, Whoop
EnvironmentPM2.5, ozone, pollen, UV, by your location in real timeAt MVP launchPurpleAir / IQAir / OpenWeather
LifestyleSleep, energy, stress, diet and workload, captured as lifestyle check-insAt MVP launchin-app check-ins
MicrobiomeGut composition → inflammation, nutrient absorption, diet responseUpload at MVPpartner API on roadmap
Labs & bloodCRP, ApoB, HbA1c, lipid panels: the objective check on the wearable signalUpload at MVPHL7/FHIR connectors 2027
Pillar 02 · Cited to live science

Every recommendation cites a real source, re-checked as new science lands.

Most apps bake in whatever the guidelines said the year they shipped. VitaCrypt re-queries the literature continuously, so a recommendation can change the week a relevant paper, GWAS hit, or guideline update appears. Every recommendation carries a real source (PubMed PMID) retrieved live, and the model cannot invent citations.

How research-watch works

  1. 1
    The model reads only public science

    An agent continuously scans public literature and guidelines. It never touches your data, it works entirely on published papers.

  2. 2
    Matching, with FHE on the roadmap

    Whether a finding applies to you is matched against your profile server-side, over a backend encrypted at rest. Running that match under FHE, so the model never sees your genotype or labs in the clear, is an R&D roadmap goal.

  3. 3
    The citation travels with the advice

    Each surfaced recommendation carries the source it rests on, graded by evidence strength.

What we actually query

Live today, we search PubMed (~40M indexed records), Europe PMC, OpenAlex, ClinVar/dbSNP and the GWAS Catalog. On the roadmap: USPSTF, NICE, WHO and Cochrane. "Cross-referenced" means we search these indexes for evidence relevant to your profile, not that millions of studies stand behind any one recommendation.

Three tiers, and a boundary

Every insight is classified before it is shown. Evidence-backed insights carry real PMIDs, a confirmed-N-of-M corroboration check across the retrieved papers, and a High / Moderate / Emerging confidence indicator. Exploratory insights, the cross-domain connections the literature has not settled, are labelled preliminary rather than asserted. And anything clinical is withheld server-side and replaced with a warm handoff to the right clinician. For established pharmacogenomic markers (starting with CYP2C9) the published CPIC consortium guidance is shown as a descriptive reference, the one place the grade comes from a clinical consortium rather than a model.

How a recommendation earns its citation

StrongestSystematic reviews & meta-analyses, then grade A/B clinical guidelines.
SupportingCohort studies, GWAS associations, mechanism papers.
FlaggedSingle studies / preprints: shown, but labelled preliminary.
Example · why "shift cardio to low-AQI hours"
A folate-cycle variant (MTHFR C677T) raises sensitivity to PM2.5-driven inflammation, so timing exertion away from pollution peaks matters more for this person.
Cited · PubMed PMC6068673 · meta-analysis
When the evidence isn't there
A claim with no strong support is shown and labelled, not asserted, and fabricated citations are stripped automatically, so a recommendation never rests on a source that does not exist.
No strong evidence yet · shown, not asserted
Pillar 03 · Personalized

The same biology reads differently depending on your genes and where you live.

Generic advice optimizes for a median person who doesn't exist. VitaCrypt reads each signal against your genotype and local exposures, so the same air, the same HRV dip, the same lab value yields a different instruction for a different person.

How a protocol is built

  1. 1
    Inputs

    Genotype + current exposures (air, season, location) + physiology (HRV, sleep, labs).

  2. 2
    Interaction reasoning

    Gene × environment interactions are evaluated against the cited literature; keeping that evaluation under FHE is on the privacy roadmap.

  3. 3
    Action

    A small set of concrete, time-bound steps, each with its evidence attached.

The evidence behind the David example

MTHFR C677T × PM2.5

The folate-cycle variant blunts homocysteine clearance; ambient PM2.5 adds inflammatory load. Together they're linked to higher ischemic-heart and vascular risk.

PubMed · PMC6068673 · meta-analysis
APOE ε4 × PM2.5

ε4 carriers show a greater neuroinflammatory response to fine-particulate exposure, observed even in young adults, relevant to long-horizon cognitive risk.

PubMed · PMC10296707 · 2023

David is a composite case from the litepaper. Values are illustrative; the gene–environment methodology and citations are real.

Pillar 04 · Private by design

Private by design, on what is true today.

Privacy here is concrete and present-day: your data is encrypted at rest under per-user keys, retention is minimal, the most sensitive data is minimized and pseudonymized before egress, and VitaCrypt is independent, not a feature of any single AI giant and built so the underlying model can be swapped rather than welded in. Stronger cryptographic guarantees, including fully homomorphic encryption, are a far-horizon roadmap item, not a current capability.

Where the line is, honestly

Today
  • Encrypted at rest, with per-user keys rolling out
  • Independent: not tied to any single AI giant; the model can be swapped
  • External AI / OCR providers clearly disclosed
Encrypted at rest, least-privilege access, minimal retention.
nownext →
Roadmap
  • Tighter identifier minimization before any external inference
  • Client-held keys (iOS Keychain / Android Keystore)
  • Blind compute (FHE): the server analyzes without decrypting
On our funded R&D roadmap, not yet live.

Is this real yet? The honest status

Today: encrypted at rest under per-user keys, minimal retention, and independence from any single AI giant. The near-term build is minimization and pseudonymization before egress and a BAA-grade zero-retention inference endpoint. Self-hosted open-weight inference and, far out, fully homomorphic encryption are roadmap, the strongest theoretical guarantee but today a poor fit for live multi-source cross-referencing. The master key is still server-side today and the platform is not yet end-to-end blind. We state this plainly.

Architecture designed for HIPAA / GDPR alignment. Working product, pre-launch; no production health data yet.

Your whole health in one profile, read together and checked against real science.

VitaCrypt opens to its first design partners in Q4 2026. Investors and prospective partners, reach out directly.